ADA and inflammatory bowel disease: Indeed, the simplicity to evaluate the ADA expression and activity associated with a good cost effectiveness ratio represent elements in favor of using this enzyme as a useful inflammatory biomarker in IBD patients, despite this additional controlled studies are needed to further corroborate the role of ADA as an independent index of inflammation in IBDs.